Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase 2 Study of Olutasidenib with Temozolomide As Maintenance Therapy in Pediatric and Young Adult Patients Newly Diagnosed with High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor IDH1 Mutations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06161974
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:49.549421+00:00
Published At
2025-02-21T00:00:00+00:00
Record Updated At
2025-02-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["High Grade Glioma", "Astrocytoma", "Astrocytoma, Grade III", "Astrocytoma, Grade IV", "Diffuse Intrinsic Pontine Glioma", "WHO Grade III Glioma", "WHO Grade IV Glioma", "Metastatic Brain Tumor", "Diffuse Midline Glioma, H3 K27M-Mutant", "Thalamus Tumor", "Spinal Tumor", "IDH1 Mutation", "IDH1 R132", "IDH1 R132C", "IDH1 R132H", "IDH1 R132S", "IDH1 R132G", "IDH1 R132L", "Oligodendroglioma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-21"
protocolSection.identificationModule.nctId
"NCT06161974"
protocolSection.identificationModule.officialTitle
"Phase 2 Study of Olutasidenib with Temozolomide As Maintenance Therapy in Pediatric and Young Adult Patients Newly Diagnosed with High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor IDH1 Mutations"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • High Grade Glioma (protocolSection.conditionsModule.conditions)
  • Astrocytoma (protocolSection.conditionsModule.conditions)
  • Astrocytoma, Grade III (protocolSection.conditionsModule.conditions)
  • Astrocytoma, Grade IV (protocolSection.conditionsModule.conditions)
  • Diffuse Intrinsic Pontine Glioma (protocolSection.conditionsModule.conditions)
  • WHO Grade III Glioma (protocolSection.conditionsModule.conditions)
  • WHO Grade IV Glioma (protocolSection.conditionsModule.conditions)
  • Metastatic Brain Tumor (protocolSection.conditionsModule.conditions)
  • Diffuse Midline Glioma, H3 K27M-Mutant (protocolSection.conditionsModule.conditions)
  • Thalamus Tumor (protocolSection.conditionsModule.conditions)
  • Spinal Tumor (protocolSection.conditionsModule.conditions)
  • IDH1 Mutation (protocolSection.conditionsModule.conditions)
  • IDH1 R132 (protocolSection.conditionsModule.conditions)
  • IDH1 R132C (protocolSection.conditionsModule.conditions)
  • IDH1 R132H (protocolSection.conditionsModule.conditions)
  • IDH1 R132S (protocolSection.conditionsModule.conditions)
  • IDH1 R132G (protocolSection.conditionsModule.conditions)
  • IDH1 R132L (protocolSection.conditionsModule.conditions)
  • Oligodendroglioma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.